Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04778449 · ClinicalTrials.gov registry record
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
A clinical trial of Cutaneous Melanoma, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT04778449 is a study of Cutaneous Melanoma that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 5,000 participants, above the 200-participant average among 30 other Cutaneous Melanoma trials with a reported enrollment target (2400% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04778449, a study of Cutaneous Melanoma, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates the extent to which lifestyle factors including mental health, social support, diet, and exercise are associated with quality of life and melanoma patient outcomes. Knowledge gained from this study may be used to guide the design of prospective clinical trials of lifestyle interventions to improve the outcomes of melanoma patients and assist doctors in counseling their patients.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Medical Chart Review
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2015-08-26 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04778449
The ClinicalTrials.gov registry entry for NCT04778449 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 200-participant average among 30 other Cutaneous Melanoma trials with a reported enrollment target (2400% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cutaneous Melanoma appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT04778449 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04778449 about?
NCT04778449 is a clinical study titled "Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma". This study investigates the extent to which lifestyle factors including mental health, social support, diet, and exercise are associated with quality of life and melanoma patient outcomes. Knowledge gained from this study may be used to guide the design of prospective clinical trials of lifestyle in...
What is the current status of trial NCT04778449?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2015-08-26. Estimated completion is 2026-12-31.
What conditions does trial NCT04778449 study?
This clinical trial studies the following conditions: Cutaneous Melanoma.
What interventions are being tested in trial NCT04778449?
The interventions under investigation include: Questionnaire Administration (OTHER), Medical Chart Review (OTHER).
Who is sponsoring clinical trial NCT04778449?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04778449 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cutaneous Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RECRUITING · Phase 1
-
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
RECRUITING · Phase 2
-
ACTengine® IMA203 Combined With mRNA-4203
RECRUITING · Phase 1
-
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RECRUITING · Phase 1
-
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.